Clock.bio: New biotech startup aims to extend human healthspan by 20 years
Endpoints News - 31-Aug-2024Revolutionary approach to reverse ageing process with CRISPR gene editing technology
Mark Kotter
Neurosurgeon, stem cell biologist and founder of bit.bio
Mark Kotter is a stem cell biologist and neurosurgeon at the University of Cambridge. Kotter is the founder and CEO of bit.bio, co-founder of the cultured meat startup Meatable and Myelopathy.org, a charity dedicated to common form of spinal cord injury. Focused on transitioning biology to engineering to address cancer and the consequences of poor health due to ageing.
Visit website: http://www.neuroscience.cam.ac.uk/directory/profile.php?=mrk25
See also: 
Bit.bio
- Human cell coding company
Details last updated 12-Apr-2021
Mark Kotter is also referenced in the following:
Global Healthspan Summit (GHS) 2025
04-Feb-2025
Longevity summit organised by Hevolution Foundation (Riyadh,Saudi Arabia)
Stem cells, lab-grown meat, and potential new medical treatments, with Mark Kotter
Mark Kotter discusses stem cells, cultivated meat, and emerging medical treatments
Mark Kotter News
Bit.bio reveals early pipeline of regenerative medicine candidates
Endpoints News - 08-Nov-2023Lead program bbHEP01 targets severe acute liver failure, with phase I trial planned for 2025
Synthetic human cells revolution: bit.bio achieves mass production breakthrough
iNews - 15-Jun-2023Paves way for potential medical research, organ manufacturing and disease treatment advances
Bit Bio secures $41.5 M funding to produce human cells
Biospace - 15-Jun-2020UK-based startup reprogramming stem cells to generate new cell therapies
